赛马鲁肽
医学
2型糖尿病
内科学
胰高血糖素样肽-1
兴奋剂
糖尿病
胰高血糖素样肽1受体
内分泌学
利拉鲁肽
受体
作者
Juan P. Frías,Melanie J. Davies,Julio Rosenstock,Federico C. Pérez Manghi,Laura Fernández Landó,Brandon K. Bergman,Bing Liu,Xuewei Cui,Katelyn Brown
标识
DOI：10.1056/nejmoa2107519
摘要
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment of type 2 diabetes. The efficacy and safety of once-weekly tirzepatide as compared with semaglutide, a selective GLP-1 receptor agonist, are unknown.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
Dean
LaTeXer
leaolf
风清扬
非而者厚
pcr163
赫若魔
Zx_1993
小杭76
小青椒
eric888
pluto
遇上就这样吧
iNk
无极微光
zcl
王昊
小c
加缪
今天只做一件事
老阎
小白白
wop111
Hello
雨0926
馆长
yznfly
皖公网安备34019202002308
